CCL2 and breast carcinoma: rs2857656 (−362 G/C), rs1024611(−2518 A/G), and rs4586 (Cys35Cys) of CCL2/MCP1 are positively associated with elevated circulating levels of CCL2 and significantly associated with an increased risk of breast cancer (43).